Sao Paulo, Brazil: The administration of the cannabinoid cannabidiol (CBD), a non-psychoactive component of marijuana, reduces anxiety in subjects with social anxiety disorder (SAD), according to clinical trial data published online in The Journal of Psychopharmacology.
Investigators at the University of Sao Paulo in Brazil assessed the anti-anxiety activity of oral doses of CBD in ten subjects in a double blind, placebo-controlled trial.
Researchers concluded, “CBD reduces anxiety in SAD and that this is related to its effects on activity in limbic and paralimbic brain areas.”
The study is the first clinical trial to investigate the effects of CBD on human pathological anxiety and its underlying brain mechanisms.
Previous studies of CBD have demonstrated the compound to possess anti-inflammatory activity, anti-cancer activity, and neuroprotective effects – among other therapeutic properties.
For more information, please contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org. Full text of the study, “Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report,” appears online in The Journal of Psychopharmacology.
Avera hontu abypajjha hontu May you be free from enmity and from mind’s sufferings. Aniga hontu sukhiattanam pariharantu May you be free from physical sufferings. Dukkha musantu May you be full of fortunes and comfortable in the body. Yathaladdha sampattito May you be free from all the conditioning of Kamma, and Mavigacchantu kammasaka emancipate from all of sufferings.
Here is the legal opinion of attorney Kirk Tousaw:
“Having read all of Prop 19, Prop 215 and the CA Health and Safety Code sections setting out their medical cannabis authorization program, I am pretty confident that Prop 19 will not negatively impact medical producers and consumers.
“For example, Prop 19 makes clear (Purposes paragraphs 7 and 8)that cities can refuse to license cannabis sales or can decide to license them but, in either case, the result is “except as permitted under Health and Safety Sections 11362.5 and 11362.7 through 11362.9.” Those are the Code sections that deal with medical production/possession.
“Again, the language isn’t perfect but the intention seems clear to me. Prop 19 is intended to legalize cannabis for everyone, leaving intact the existing regime related to medical use.”
Kirk Tousaw has practiced law on both sides of the US/ Canada border since 1998. He has trial and appellate experience in both small-scale and large-scale criminal and civil litigation. Kirk is a member of the Board of Directors of the BC Civil Liberties Association and the Chair of the Association’s Drug Policy Committee. He is also the President of the BC chapter of End Prohibition. Kirk has researched, written and spoken extensively on drug and criminal policy issues, including testimony before the Justice Committee of the House of Commons. His Master’s in Law thesis explored US Constitutional issues surrounding cannabis prohibition and he writes frequently on the laws related to drugs.
Once all the facts are known, it becomes clear that America’s marijuana laws need reform. This issue must be openly debated using only the facts. Groundless claims, meaningless statistics, and exaggerated scare stories that have been peddled by politicians and prohibitionists for the last 60 years must be rejected.
TOBACCO …………………… 400,000
ALCOHOL …………………… 100,000
ALL LEGAL DRUGS ………….20,000
ALL ILLEGAL DRUGS ……….15,000
MARIJUANA …………………. 0
Source: United States government…
National Institute on Drug Abuse,
Bureau of Mortality Statistics